Comments
Loading...

InspireMD

NSPRNASDAQ
Logo brought to you by Benzinga Data
$2.78
0.176.68%
At Close: -
$2.62
-0.16-5.76%
After Hours: Sep 18, 4:20 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$5.15
Lowest Price Target1
$4.50
Consensus Price Target1
$4.80

InspireMD (NASDAQ:NSPR) Stock, Analyst Ratings, Price Targets, Forecasts

InspireMD Inc has a consensus price target of $4.8 based on the ratings of 3 analysts. The high is $5.15 issued by Alliance Global Partners on March 31, 2023. The low is $4.5 issued by Piper Sandler on September 17, 2024. The 3 most-recent analyst ratings were released by Piper Sandler on September 17, 2024, November 2, 2023, and June 12, 2023, respectively. With an average price target of $4 between Piper Sandler, there's an implied 52.67% upside for InspireMD Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Piper Sandler
National Alliance Securities
Alliance Global Partners

1calculated from analyst ratings

Analyst Ratings for InspireMD

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for InspireMD (NSPR) stock?

A

The latest price target for InspireMD (NASDAQ:NSPR) was reported by Piper Sandler on September 17, 2024. The analyst firm set a price target for $4.50 expecting NSPR to rise to within 12 months (a possible 61.87% upside). 2 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for InspireMD (NSPR)?

A

The latest analyst rating for InspireMD (NASDAQ:NSPR) was provided by Piper Sandler, and InspireMD reiterated their overweight rating.

Q

When was the last upgrade for InspireMD (NSPR)?

A

There is no last upgrade for InspireMD

Q

When was the last downgrade for InspireMD (NSPR)?

A

There is no last downgrade for InspireMD.

Q

When is the next analyst rating going to be posted or updated for InspireMD (NSPR)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of InspireMD, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for InspireMD was filed on September 17, 2024 so you should expect the next rating to be made available sometime around September 17, 2025.

Q

Is the Analyst Rating InspireMD (NSPR) correct?

A

While ratings are subjective and will change, the latest InspireMD (NSPR) rating was a reiterated with a price target of $4.50 to $4.50. The current price InspireMD (NSPR) is trading at is $2.78, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch